Is this you? Create Your Porfile
Avatar

Augustus O. Okhamafe

BioMarin Pharmaceutical

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Augustus O. Okhamafe is active.

Explore More

Publication

Featured researches published by Augustus O. Okhamafe.

Archive | 2010

VARIANTS OF C-TYPE NATRIURETIC PEPTIDE

Daniel J. Wendt; Shinong Long; Sianna Castillo; Christopher P. Price; Mika Aoyagi-Scharber; Michel Claude Vellard; Augustus O. Okhamafe

Archive | 2008

Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

Daniel I. Oppenheimer; Alejandro Dorenbaum; Augustus O. Okhamafe; Erik Foehr; Sianna Castillo; Paul John Kostel

Archive | 2011

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

Vish Koppaka; Michel Claude Vellard; Augustus O. Okhamafe; Kidisti Araya

Archive | 2012

Dihydropyridophthalazinone inhibitors of poly (adp-ribose) polymerase (parp) for the treatment of multiple myeloma

Ying Feng; Andres A. Gutierrez; Yuqiao Shen; Evelyn Wang; Augustus O. Okhamafe; Christopher P. Price; Tianwei Chou

Archive | 2008

Tetrahydrobiopterin compositions and methods of measuring

Daniel I. Oppenheimer; Alejandro Dorenbaum; Augustus O. Okhamafe; Erik Foehr; Sianna Castillo; Paul John Kostel

Archive | 2012

Dry blend formulation of tetrahydrobiopterin

Tianwei Chou; Augustus O. Okhamafe

Archive | 2011

Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

Augustus O. Okhamafe; Sean M. Bell; G. Nick Zecherle; Kris Antonsen; Yanhong Zhang; Kieu Y. Ly; Paul A. Fitzpatrick; Emil D. Kakkis; Michel Claude Vellard; Daniel J. Wendt; Mubarack Muthalif

Archive | 2017

FORMULACIONES DE TRIPEPTIDIL PEPTIDASA 1 (TPP1) Y MÉTODOS DE TRATAMIENTO DE UNA LIPOFUSCINOSIS CEROIDE NEURONAL (CLN2)

Charles A. O'Neill; Augustus O. Okhamafe; Saeed Moshashaee; Thomas Lester

Archive | 2017

USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA

Sherry Bullens; Stuart Bunting; Tianwei Chou; Augustus O. Okhamafe; Christopher P. Price; Daniel J. Wendt; Clarence Yap

Archive | 2016

Tpp1 formulations and methods for treating cln2 disease

Thomas Lester; Saeed Moshashaee; Augustus O. Okhamafe; Charles A. O'Neill

Explore More

Collaboration

Dive into the Augustus O. Okhamafe's collaboration.

Top Co-Authors
Avatar

Daniel J. Wendt

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Michel Claude Vellard

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Sianna Castillo

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Alejandro Dorenbaum

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Daniel I. Oppenheimer

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Emil D. Kakkis

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Erik Foehr

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Mubarack Muthalif

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Paul A. Fitzpatrick

BioMarin Pharmaceutical

View shared research outputs
Top Co-Authors
Avatar

Paul John Kostel

BioMarin Pharmaceutical

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge